Who founded Dystrogen Therapeutics?

Dystrogen Therapeutics was founded by Maria Siemionow, Paul Lewicki in 2017.

How much funding has Dystrogen Therapeutics raised?

Dystrogen Therapeutics has disclosed $1.1M raised across 1 round.

Where is Dystrogen Therapeutics headquartered?

Dystrogen Therapeutics is headquartered in Chicago, US.

Dystrogen Therapeutics

Chicago, US · Founded 2017 · Delaware corporation

Find your way into Dystrogen Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Dystrogen Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Dystrogen Therapeutics develops chimeric cell therapies created by fusing donor and recipient bone marrow-derived stem cells to address the immune system's response to foreign tissues and donor organs. The company operates in the therapeutics and cell therapy field.

Biotech Healthtech

Founders & leadership

Dystrogen Therapeutics was founded in 2017 by Maria Siemionow and Paul Lewicki.

Maria SiemionowFounder & Chief Scientific Officer

Paul LewickiCo-Founder & Board Member

Kris SiemionowCo-Founder & CEO

Reported raises · per SEC filings

Form D private placements

$1.1M disclosed across 1 round · 2019

▶$1.1MraisedAug 2019 · 14 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Kris SiemionowDirector

Offering amount: $5M
Amount sold: $1.1M
Minimum investment: $85
First sale: Aug 2019
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Dystrogen Therapeutics do?: Dystrogen Therapeutics develops chimeric cell therapies created by fusing donor and recipient bone marrow-derived stem cells to address the immune system's response to foreign tissues and donor organs. The company operates in the therapeutics and cell therapy field.
Who founded Dystrogen Therapeutics?: Dystrogen Therapeutics was founded by Maria Siemionow, Paul Lewicki in 2017.
How much funding has Dystrogen Therapeutics raised?: Dystrogen Therapeutics has disclosed $1.1M raised across 1 round.
Where is Dystrogen Therapeutics headquartered?: Dystrogen Therapeutics is headquartered in Chicago, US.